L3VLUP
ProSign in

LNTH · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

LNTHJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • LNTH
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterLNTHJNJ
Q3 20201 holders, $34m30 holders, $26.2bn
Q4 20201 holders, $36m32 holders, $26.6bn
Q1 20212 holders, $71m31 holders, $25.3bn
Q2 20213 holders, $71m37 holders, $25.6bn
Q3 20212 holders, $57m40 holders, $24.1bn
Q4 20212 holders, $64m33 holders, $25.2bn
Q1 20228 holders, $299m35 holders, $28.2bn
Q2 20229 holders, $313m33 holders, $26.9bn
Q3 20229 holders, $357m36 holders, $25.4bn
Q4 202212 holders, $312m35 holders, $27.6bn
Q1 202316 holders, $723m42 holders, $24.5bn
Q2 202318 holders, $897m38 holders, $25.0bn
Q3 20239 holders, $628m37 holders, $18.9bn
Q4 20238 holders, $470m31 holders, $19.0bn
Q1 20249 holders, $431m32 holders, $19.7bn
Q2 20248 holders, $577m35 holders, $20.4bn
Q3 20247 holders, $830m28 holders, $22.3bn
Q4 20247 holders, $1.1bn37 holders, $20.4bn
Q1 20255 holders, $1.3bn32 holders, $20.5bn
Q2 20259 holders, $1.4bn31 holders, $18.4bn
Q3 20258 holders, $572m32 holders, $23.7bn
Q4 20256 holders, $862m29 holders, $27.8bn
Q1 20266 holders, $963m34 holders, $35.6bn
Q2 202610 holders, $1.6bn33 holders, $39.1bn
LNTH

Lantheus HLDGS Inc

Holders
10
Reported value
$1.6bn
Buyers
20
Sellers
9

Breadth +11 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
33
Reported value
$39.1bn
Buyers
18
Sellers
21

Breadth -3 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2026

Among the 36 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only LNTH (3)

ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Point72 Asset Management LP

Only JNJ (26)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Invesco Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Soros Fund Management LLC, Squarepoint Ops LLC, Verition Fund Management LLC, Voloridge Investment Management LLC, Wellington Management Group LLP, and 1 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →